BSE Live
Oct 31, 16:01Prev. Close
437.85
Open Price
440.00
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)
NSE Live
Oct 31, 15:54Prev. Close
439.45
Open Price
440.85
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)
| Profit & Loss account of Venus Remedies (in Rs. Cr.) | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 | |
| 12 mths | 12 mths | 12 mths | 12 mths | 12 mths | ||
| INCOME | ||||||
| Revenue From Operations [Gross] | 647.29 | 591.45 | 553.38 | 598.65 | 540.50 | |
| Less: Excise/Sevice Tax/Other Levies | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Revenue From Operations [Net] | 647.29 | 591.45 | 553.38 | 598.65 | 540.50 | |
| Total Operating Revenues | 647.89 | 601.45 | 555.51 | 598.65 | 548.12 | |
| Other Income | 20.96 | 11.58 | 10.32 | 8.31 | 19.63 | |
| Total Revenue | 668.84 | 613.03 | 565.83 | 606.96 | 567.75 | |
| EXPENSES | ||||||
| Cost Of Materials Consumed | 348.77 | 344.28 | 317.79 | 381.97 | 347.94 | |
| Purchase Of Stock-In Trade | 25.04 | 13.07 | 5.16 | 0.00 | 0.00 | |
| Operating And Direct Expenses | 23.57 | 18.50 | 14.37 | 12.78 | 11.16 | |
| Changes In Inventories Of FGWIP And Stock In Trade | 4.81 | -2.66 | 8.04 | 3.48 | -7.15 | |
| Employee Benefit Expenses | 80.49 | 71.50 | 61.33 | 52.33 | 46.02 | |
| Finance Costs | 0.07 | 0.09 | 0.29 | 0.48 | 13.02 | |
| Depreciation And Amortisation Expenses | 22.51 | 26.44 | 32.30 | 33.53 | 35.28 | |
| Other Expenses | 101.68 | 97.15 | 88.62 | 85.97 | 96.37 | |
| Total Expenses | 606.93 | 568.39 | 527.90 | 570.55 | 542.64 | |
| Profit/Loss Before Exceptional, ExtraOrdinary Items And Tax | 61.91 | 44.64 | 37.93 | 36.41 | 25.11 | |
| Exceptional Items | 9.91 | 0.00 | 0.00 | 0.00 | 23.44 | |
| Profit/Loss Before Tax | 71.83 | 44.64 | 37.93 | 36.41 | 48.55 | |
| Tax Expenses-Continued Operations | ||||||
| Current Tax | 18.93 | 11.74 | 0.00 | 0.00 | 0.00 | |
| Less: MAT Credit Entitlement | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Deferred Tax | 4.65 | 3.93 | 11.36 | -4.32 | -13.21 | |
| Other Direct Taxes | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Total Tax Expenses | 26.51 | 16.15 | 11.36 | -4.32 | -13.21 | |
| Profit/Loss After Tax And Before ExtraOrdinary Items | 45.31 | 28.49 | 26.57 | 40.72 | 61.77 | |
| Profit/Loss From Continuing Operations | 45.31 | 28.49 | 26.57 | 40.72 | 61.77 | |
| Profit/Loss For The Period | 45.31 | 28.49 | 26.57 | 40.72 | 61.77 | |
| Minority Interest | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Consolidated Profit/Loss After MI And Associates | 45.31 | 28.49 | 26.57 | 40.72 | 61.77 | |
| OTHER ADDITIONAL INFORMATION | ||||||
| EARNINGS PER SHARE | ||||||
| Basic EPS (Rs.) | 34.00 | 21.00 | 20.00 | 31.00 | 50.00 | |
| Diluted EPS (Rs.) | 34.00 | 21.00 | 20.00 | 31.00 | 50.00 | |
| DIVIDEND AND DIVIDEND PERCENTAGE | ||||||
| Equity Share Dividend | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Tax On Dividend | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
12.08.2025
Venus Remedies Consolidated June 2025 Net Sales at Rs 131.90 crore, up 21.44% Y-o-Y
05.08.2025
Venus Remedies Standalone June 2025 Net Sales at Rs 131.85 crore, up 24.55% Y-o-Y
28.05.2025
Venus Remedies Standalone March 2025 Net Sales at Rs 194.04 crore, up 10.78% Y-o-Y
05.02.2025
Venus Remedies Standalone December 2024 Net Sales at Rs 172.54 crore, up 31.48% Y-o-Y
12.08.2025
Venus Remedies Consolidated June 2025 Net Sales at Rs 131.90 crore, up 21.44% Y-o-Y
05.08.2025
Venus Remedies Standalone June 2025 Net Sales at Rs 131.85 crore, up 24.55% Y-o-Y
28.05.2025
Venus Remedies Standalone March 2025 Net Sales at Rs 194.04 crore, up 10.78% Y-o-Y
05.02.2025
Venus Remedies Standalone December 2024 Net Sales at Rs 172.54 crore, up 31.48% Y-o-Y